| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President &CEO
1 company
Struthers Richard Scott serves as a President &CEO at CRNX. Across recent SEC filings that breaks down to 2 buys and 21 sells.
Historically, Struthers Richard Scott's trades have earned a middling insider score of 54/100 across 14 rated trades. Over a 12-month horizon, 46.2% of those trades were profitable, with an average 12-month return of -30.3%.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 7, 2021 | CRNX Crinetics Pharmaceuticals, Inc. | President &CEO | Sell | 30,000 | $25.00 | $750,000.00 | -25.0% | -2.3% | -14.3% | |
| Dec 3, 2020 | CRNX Crinetics Pharmaceuticals, Inc. | President &CEO | Buy | 5,000 | $13.00 | $65,000.00 | -500.0% | - | - | |
| Jul 16, 2020 | CRNX Crinetics Pharmaceuticals, Inc. | President &CEO | Sell | 35,000 | $14.88 | $520,829.75 | -3.8% | - | - |